Structural Formula (Doc08 0000 01 V2)
Docetaxel Injection, Solution, Concentrate
Product Images NDC 71288-152
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 71288-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Doc08 0000 02 V2)
This text appears to show a chart representing the probability of disease-free survival over time in months. The values on the x-axis range from 0 to 66 months, while the y-axis shows the probability of disease-free survival in percentage.*
Figure 2 (Doc08 0000 03 V2)
Figure 3 (Doc08 0000 04)
This text provides information about cumulative family overall survival data, with emphasis on the log-rank test result of p=0.010. The graph appears to show survival time in months.*
Figure 4 (Doc08 0000 05)
Figure 5 (Doc08 0000 06 V3)
Figure 6 (Doc08 0000 07 V2)
Figure 7 (Doc08 0000 08 V2)
Figure 8 (Doc08 0000 09 V3)
Figure 9 (Doc08 0000 10 V2)
The text describes survival probabilities at different time intervals in months. The survival probabilities are given in percentages at various time points ranging from 18 to 72 months.*
Figure 10 (Doc08 0000 11 V2)
Principal Display Panel – Docetaxel Injection, Usp, 20 mg Per mL Vial Label (Doc08 0000 12 V4)
This text contains information about a cytotoxic agent called docetaxel USP with a concentration of 20 mg per mL. It is intended for intravenous use only and comes in a 1 mL single-dose vial. The product is manufactured by Meitheal Pharmaceuticals and should be added to infusion solutions as per the package insert instructions. The manufacturer's address is provided as 8700 W Bryn Mawr, Ste 600S, Chicago, IL 60631 (USA). Please refer to the lot number on the packaging for tracking purposes.*
Principal Display Panel – Docetaxel Injection, Usp, 20 mg Per mL Carton (Doc08 0000 13 V4)
This text provides detailed information about Docetaxel Bronty, a cytotoxic agent used for intravenous injection in medical settings. It contains important instructions for healthcare professionals, such as the dosage (20 mg per mL), the route of administration (intravenous use only), and the proper handling of the single-dose vials. The text emphasizes caution due to the cytotoxic nature of the drug, and it reminds to discard any unused portion properly. Reading and understanding this information is essential for safe administration and disposal of the medication.*
Principal Display Panel – Docetaxel Injection, Usp, 80 mg Per 4 mL Vial Label (Doc08 0000 14 V4)
This is a description of a medication called Docetaxel, which is an injection containing 80 mg per 4 mL (20 mg per mL) for intravenous use only. It is a cytotoxic agent and should be added to an infusion solution. The medication is stored between 2° and 25°C, protected from light. The manufacturer is Meitheal Pharmaceuticals based in Chicago, IL, USA. A caution is given to discard any unused portion of the 4 mL single-dose vial.*
Principal Display Panel – Docetaxel Injection, Usp, 80 mg Per 4 mL Carton (Doc08 0000 15 V4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
